Vaxart Announces Dosing First Subject in Phase 1 Clinical Trial of Its Oral Tablet COVID-19 Vaccine
SOUTH SAN FRANCISCO, Calif., Oct. 13, 2020 (GLOBE NEWSWIRE) — Vaxart, Inc., (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral vaccines that are administered by tablet rather than by injection, today announced that the…
Mirikizumab Shows Continued Symptom Improvement and Reduction of Intestinal Inflammation in Patients with Crohn’s Disease in 52-Week Phase 2 Trial
INDIANAPOLIS, Oct. 12, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE:LLY) announced today new efficacy and safety data from the Phase 2 SERENITY study evaluating mirikizumab in patients with moderately to severely active…
Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and the Bill & Melinda Gates Foundation, as part of the COVID-19 Therapeutics Accelerator, have entered into an agreement to…
FDA Approves Additional Doses of Trulicity (dulaglutide) for the Treatment of Type 2 Diabetes
INDIANAPOLIS, Sept. 3, 2020 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) today approved two additional doses of Eli Lilly and Company’s (NYSE: LLY) Trulicity® (dulaglutide). The approval expands the label of once-weekly Trulicity to…
Incyte Announces that the TRuE-AD2 Pivotal Trial of Ruxolitinib Cream Met its Primary Endpoint in Patients with Atopic Dermatitis
WILMINGTON, Del.–(BUSINESS WIRE)–Jan. 28, 2020– Incyte (Nasdaq:INCY) today announced positive topline results from its randomized, vehicle-controlled, pivotal Phase 3 TRuE-AD2 study evaluating the safety and efficacy of ruxolitinib cream in adolescent and…
Rise in serious harm to children caused by powerful painkillers, says study
The proportion of high-strength painkiller poisonings among children which result in emergency hospital admissions has increased, according to research published in the peer-reviewed journal Clinical Toxicology. A study involving more…
Regional trends in overdose deaths reveal multiple opioid epidemics, according to new study
The United States is suffering from several different simultaneous opioid epidemics, rather than just a single crisis, according to an academic study of deaths caused by drug overdoses. David Peters,…
Gay, bisexual men increasingly agree: HIV ‘undetectable equals untransmittable’
Extensive evidence from HIV prevention research studies has firmly established that “Undetectable Equals Untransmittable,” or U=U. This means that people living with HIV who achieve and maintain an undetectable viral…
Study highlights ‘worrying’ increase in misuse of non-opioid medications
A major new analysis of the non-opioid medications, gabapentin and baclofen, shows “worrying” increases in related suicide attempts and hospital admissions in US adults since 2013—coinciding with a decrease in…
Cannabis reduces headache and migraine pain by nearly half
Inhaled cannabis reduces self-reported headache severity by 47.3% and migraine severity by 49.6%, according to a recent study led by Carrie Cuttler, a Washington State University assistant professor of psychology.…